Angiogenesis is a complex biological phenomenon
crucial for a correct embryonic development and for
post-natal growth. In adult life, it is a tightly regulated
process confined to the uterus and ovary during the different
phases of the menstrual cycle and to the heart
and skeletal muscles after prolonged and sustained
physical exercise. Conversly, angiogenesis is one of
the major pathological changes associated with several
complex diseases like cancer, atherosclerosis, arthritis,
diabetic retinopathy and age-related macular
degeneration. Among the several molecular players involved
in angiogenesis, some members of VEGF family,
VEGF-A, VEGF-B and placenta growth factor
(PlGF), and the related receptors VEGF receptor 1
(VEGFR-1, also known as Flt-1) and VEGF receptor 2
(VEGFR-2, also known as Flk-1 in mice and KDR in human)
have a decisive role. In this review, we describe
the discovery and molecular characteristics of PlGF,
and discuss the biological role of this growth factor in
physiological and pathological conditions. |